1
Amy H. Comander, MD Medical Director, Auerbach Breast Center Newton-Wellesley Hospital Kimberly DeLeonardis, MS, CGC Cancer Genetics and Prevention Program Beth Israel Deaconess Medical Center Camila Gabriel, MS Center for Cancer Genetics and Prevention Dana-Farber Cancer Institute Debbi Shamon, LICSW In private practice in Boston, MA Lauren Corduck Founder & Executive Director, Oneinforty BRCA-positive ovarian cancer patient Whitfield B. Growdon, MD Center for Gynecologic Oncology Massachusetts General Hospital wednesday may 23, 2018 7:00 - 9:00 pm This symposium is FREE OF CHARGE and OPEN TO THE GENERAL PUBLIC. Kosher refreshments will be served. Please contact Lauren Corduck at 617.823.3630 or laurenc @ oneinforty.org with questions. J oin us to learn from experts about Ashkenazi Jews’ one-in-forty risk of inheriting a BRCA gene mutation. Having a BRCA gene mutation significantly increases one’s risk of developing ovarian, prostate and male and female breast cancer. Panelists will discuss BRCA gene mutation screening, genetic counseling, managing cancer risk and resources available for BRCA positive individuals and their families. Individuals who have a BRCA gene mutation will share their stories followed by a Q&A session. Temple Beth Elohim 10 Bethel Road, Wellesley, MA Presented by Oneinforty, a nonprofit organization that raises awareness of the one-in-forty risk to Ashkenazi Jews of inheriting BRCA gene mutations and provides the support individuals and families need to effectively manage their cancer risk. Visit www.oneinforty.org to learn more. REGISTER TODAY AT: http://oneinforty.org/events Understanding the Jewish-Cancer Connection Knowledge is Empowering symposium panelists

Knowledge is Empoweringoneinforty.org/wp-content/uploads/2018/04/5-23-18-Onein...2018/04/05  · Amy H. Comander, MD Medical Director, Auerbach Breast Center Newton-Wellesley Hospital

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Knowledge is Empoweringoneinforty.org/wp-content/uploads/2018/04/5-23-18-Onein...2018/04/05  · Amy H. Comander, MD Medical Director, Auerbach Breast Center Newton-Wellesley Hospital

Amy H. Comander, MDMedical Director, Auerbach Breast CenterNewton-Wellesley Hospital

Kimberly DeLeonardis, MS, CGCCancer Genetics and Prevention ProgramBeth Israel Deaconess Medical Center

Camila Gabriel, MSCenter for Cancer Genetics and PreventionDana-Farber Cancer Institute

Debbi Shamon, LICSWIn private practice in Boston, MA

Lauren CorduckFounder & Executive Director, OneinfortyBRCA-positive ovarian cancer patient

Whitfield B. Growdon, MDCenter for Gynecologic OncologyMassachusetts General Hospital

wednesdaymay 23, 20187:00 - 9:00 pm

This symposium is FREE OF CHARGE and OPEN TO THE GENERAL PUBLIC. Kosher refreshments will be served. Please contact Lauren Corduck at

617.823.3630 or [email protected] with questions.

Join us to learn from experts about Ashkenazi Jews’ one-in-forty risk

of inheriting a BRCA gene mutation. Having a BRCA gene mutation significantly increases one’s risk of developing ovarian, prostate and male and female breast cancer.

Panelists will discuss BRCA gene mutation screening, genetic counseling, managing cancer risk and resources available for BRCA positive individuals and their families.

Individuals who have a BRCA gene mutation will share their stories followed by a Q&A session.

Temple Beth Elohim10 Bethel Road, Wellesley, MA

Presented by Oneinforty, a nonprofit organization that raises awareness of the one-in-forty risk to Ashkenazi Jews of inheriting BRCA gene mutations and provides the support individuals and families need to effectively manage their cancer risk.Visit www.oneinforty.org to learn more.

REGISTER TODAY AT: http://oneinforty.org/events

U n d e r sta n d i n g th e J e w i s h - C a n c e r C o n n e c t i o n

Knowled g e is E m powe r i ng

sym

posi

um p

anel

ists